Spires J, Gladden LB, Grassi B, Saidel GM, Lai N. Model analysis of the relationship between intracellular PO2 and energy demand in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 303: R1110 -R1126, 2012. First published September 12, 2012 doi:10.1152/ajpregu.00106.2012.-On the basis of experimental studies, the intracellular O2 (iPO2)-work rate (WR) relationship in skeletal muscle is not unique. One study found that iPO2 reached a plateau at 60% of maximal WR, while another found that iPO2 decreased linearly at higher WR, inferring capillary permeability-surface area (PS) and blood-tissue O2 gradient, respectively, as alternative dominant factors for determining O2 diffusion changes during exercise. This relationship is affected by several factors, including O2 delivery and oxidative and glycolytic capacities of the muscle. In this study, these factors are examined using a mechanistic, mathematical model to analyze experimental data from contracting skeletal muscle and predict the effects of muscle contraction on O2 transport, glycogenolysis, and iPO2. The model describes convection, O2 diffusion, and cellular metabolism, including anaerobic glycogenolysis. Consequently, the model simulates iPO2 in response to muscle contraction under a variety of experimental conditions. The model was validated by comparison of simulations of O2 uptake with corresponding experimental responses of electrically stimulated canine muscle under different O 2 content, blood flow, and contraction intensities. The model allows hypothetical variation of PS, glycogenolytic capacity, and blood flow and predictions of the distinctive effects of these factors on the iPO 2-contraction intensity relationship in canine muscle. Although PS is the main factor regulating O 2 diffusion rate, model simulations indicate that PS and O 2 gradient have essential roles, depending on the specific conditions. Furthermore, the model predicts that different convection and diffusion patterns and metabolic factors may be responsible for different iPO 2-WR relationships in humans. oxygen diffusion; convection; bioenergetics; exercise; glycolysis; contraction THE SKELETAL MUSCLE INTRACELLULAR PO 2 (iPO 2 )-exercise intensity relationship was previously investigated to study the regulatory mechanisms of O 2 consumption (V O 2 ) in working skeletal muscle (49, 55, 57) . In particular, from these NMR studies in humans, skeletal muscle iPO 2 was inferred from measurements of deoxymyoglobin concentration during muscle contraction. The relationships between iPO 2 and metabolic intensity [i.e., work rates (WR)], however, were dissimilar. Molé et al. (49) reported that iPO 2 decreased linearly as WR increased above 50 -60% of peak V O 2 (V O 2peak ), whereas Richardson et al. (55, 57) found that iPO 2 was low and constant above 60% of V O 2peak during knee extensor exercise. In addition, Molé et al. inferred that the blood-tissue O 2 gradient, rather than capillary permeability-surface area (PS), as proposed by Richardson et al., was the dominant factor determining O 2 diffusion. PS is an overall transport coefficient equal to the rate of O 2 transport between capillary blood and myocytes divided by the corresponding O 2 concentration difference. It is directly related to diffusion conductance or diffusing capacity. Previous mathematical models suggested that O 2 diffusion primarily depends on the spacing and clearance of RBCs (18, 26) , two factors that contribute to PS. Therefore, the role of the O 2 gradient and PS on the regulation of O 2 diffusion at different muscle contraction intensities is still not conclusive.
cle contraction. The relationships between iPO 2 and metabolic intensity [i.e., work rates (WR)], however, were dissimilar. Molé et al. (49) reported that iPO 2 decreased linearly as WR increased above 50 -60% of peak V O 2 (V O 2peak ), whereas Richardson et al. (55, 57) found that iPO 2 was low and constant above 60% of V O 2peak during knee extensor exercise. In addition, Molé et al. inferred that the blood-tissue O 2 gradient, rather than capillary permeability-surface area (PS), as proposed by Richardson et al., was the dominant factor determining O 2 diffusion. PS is an overall transport coefficient equal to the rate of O 2 transport between capillary blood and myocytes divided by the corresponding O 2 concentration difference. It is directly related to diffusion conductance or diffusing capacity. Previous mathematical models suggested that O 2 diffusion primarily depends on the spacing and clearance of RBCs (18, 26) , two factors that contribute to PS. Therefore, the role of the O 2 gradient and PS on the regulation of O 2 diffusion at different muscle contraction intensities is still not conclusive.
Because these studies were done on different muscles undergoing different exercise protocols, they are difficult to compare directly. V O 2 and blood flow (Q ) distribution in skeletal muscle likely differ in the two experimental protocols. In particular, single-legged knee extensor exercise results in much higher Q and V O 2 per unit muscle than does plantar flexion or two-legged cycle ergometry (6, 49, 56) . Confounding the interpretation of these results further is the heterogeneity of PO 2 within the muscle, which affects NMR measurements and subsequent estimates of iPO 2 .
O 2 delivery and cellular metabolism are the main processes that can limit the dynamic response of skeletal muscle V O 2 during contraction (63) . Therefore, besides O 2 convection and diffusion effects on iPO 2 , the mechanisms regulating the utilization of aerobic and anaerobic energy sources must be taken into account in quantifying the iPO 2 -WR relationship during higher metabolic demand. Previous studies using the canine gastrocnemius model have provided insightful information on the factors limiting muscle oxidative metabolism during contraction (23) (24) (25) . At submaximal metabolic intensity (23, 24) (e.g., 60% of V O 2peak ), V O 2 kinetics responses appear to be limited primarily by cellular metabolism; at higher metabolic intensity (100% of V O 2peak ), O 2 delivery (i.e., diffusion and convection) and metabolic processes appear to play a role (25) .
However, these studies of skeletal muscle contraction did not evaluate iPO 2 or the rate of O 2 diffusion.
In spontaneously perfused muscle, Q increases with V O 2 and energy demands of the muscle. Imposing an elevated Q would not be expected to alter V O 2 but might affect iPO 2 or other key metabolites. Although the effects of Q on the kinetics of V O 2 have been determined experimentally, the effects of elevated Q and PS on iPO 2 in canine muscle are not known.
A quantitative approach proposed by Wagner (64) was successfully applied to understand the interaction between O 2 convection and diffusion and their roles in determining maximal V O 2 . However, this approach is limited to steady-state analysis, and the interaction between O 2 delivery and aerobic and anaerobic systems is not considered. In response to muscle contraction, the metabolic fluxes associated with the glycolytic and oxidative systems are regulated by compensatory mechanisms involving ATP/ADP and NADH/NAD changes (7) . Therefore, glycolytic and oxidative systems are indirectly related through the metabolic fluxes that share common substrates. Thus anaerobic glycolysis can indirectly affect iPO 2 in skeletal muscle at higher exercise intensity.
To quantify the relationships between iPO 2 , O 2 utilization, and WR in skeletal muscle at higher exercise intensity, a mechanistic, mathematical model of O 2 transport and metabolism can be used. For this purpose, a model of anaerobic glycogenolysis (44) was combined with a model of O 2 transport and utilization (43) . The resulting model delivers O 2 by convection and diffusion and supplies energy by oxidative and glycogenolytic mechanisms. Accordingly, it can simulate skeletal muscle responses to submaximal and maximal metabolic demands. Model outputs compared with experimental data obtained under different experimental conditions provide model validation. Model simulations of canine skeletal muscle during contraction show how the iPO 2 -energy demand relationship is affected by PS, blood perfusion patterns, and oxidative and glycogenolytic characteristics. Differences in O 2 delivery and energy utilization patterns associated with various experimental conditions can explain and reconcile apparent differences in the iPO 2 -WR relationship at different levels of metabolic demand. Since simultaneous measurements of tissue metabolites and iPO 2 with contracting muscle are difficult to obtain, a mechanistic, mathematical model is used to simulate the metabolic response to higher metabolic rates. These simulations can provide a reliable basis for evaluating 1) the importance of O 2 gradient and PS in the control of O 2 diffusion and 2) the conditions under which iPO 2 decreases linearly or remains constant in response to increasing muscle contraction intensity. depend on time (t) and tissue location, as indicated by the cumulative muscle volume () from the arterial input ( ϭ 0) to the venous output ( ϭ V mus). On the basis of a dynamic O2 balance in blood (43) 
Glossary
where fb ϭ Vcap/Vmus, DO 2 ,b is effective axial dispersion coefficient in blood, J O2 b,c is transport flux of O2 between blood and tissue cells, and ␥ O 2 ,b is a coefficient that accounts for the equilibrium between free and bound O 2 in blood (see APPENDIX B) . A similar dynamic mass balance describes lactate and pyruvate concentrations
Concentration dynamics in extravascular tissue. The dynamics of free O2 concentration in muscle cells of tissue can be described as
where f c ϭ Vtis/Vmus ϭ 1 Ϫ fb, DO 2 ,c is the effective axial dispersion coefficient in blood, and ␥O 2 ,c is a coefficient that accounts for the equilibrium between free and bound O2 in muscle cells. For j species other than O2 (see APPENDIX A), the dynamic mass balance in tissue has the following general form 
where the transport flux is nonzero only for lactate and pyruvate. The net rate of a metabolic reaction producing and utilizing substrate j is
where S↔P is the reaction flux rate for which the species j is involved as substrate (S) or product (P) and ␤ j,S↔P is the corresponding stoichiometric coefficient. Boundary and initial conditions. For capillary blood, we assume that the input O 2, lactate, and pyruvate concentrations from arterial blood are known and that the output O 2, lactate, and pyruvate concentrations leaving the capillaries have negligible gradients in the direction of Q
Initially, the concentrations are distributed in a resting, steady state
Concentration constraints. The concentrations of ATP, ADP, and AMP, phosphocreatine (PCr) and creatine (Cr), and NADH and NAD are related by mass conservation of adenosine (A), Cr (C), and NAD (N) within the cell. For constant total concentrations and volumes of the tissue
Another constraint associated with the application of this model is the assumption of constant glycogen concentration. Blood-cell transport fluxes. The capillary-tissue transport of O 2 between blood and muscle cells depends on the PS and their free O2 concentrations
When a change occurs in muscle Q , PS is assumed to change with the same dynamic pattern (43) . For a step-up change of Q with characteristic time constant Q , we assume
where PS max is the maximal value and PS rest is the value at resting, steady state, when t Յ t0. When Q is pump-perfused (PP), PS is set at a constant PS max . For lactate and pyruvate (j ϭ lac, pyr), the net transport fluxes J j b,c between blood and tissue depend on their concentrations (Cj,b and Cj,c) according to carrier-mediated transport (see Table 7 ) (14)
Metabolic fluxes. The mathematical model describes the metabolic reactions within the cells (Fig. 1) , including the glycogenolytic pathway, and ATPase, creatine kinase, and adenylate kinase reactions, as well as oxidative phosphorylation. Most of the reaction fluxes are described by ordered bi-bi reactions (see APPENDIX B) (44)
where C a, Cb, Cp, and Cq are substrates and products of the enzymatic reaction i, respectively, and Ka, Kb, Kp, and Kq are Michaelis-Menten constants. The maximal metabolic flux reverse and forward for each i reaction are calculated using the Haldane relation (44)
These Vmax,f,i values do not change with contraction intensity. Energy supply and demand. Fluxes related to energy supply and demand change depending on experimental conditions. The energy demand is associated with the ATPase reaction described by mass action (44) ATPase ϭ k ATPase C ATP (14) The fluxes of energy supply are related to glycogenolysis (⌽ gly ATP ϭ PFK ϩ PGK ϩ PK), oxidative phosphorylation (OxP), creatine kinase (CK), and adenylate kinase (ADK). At steady state, flux of energy demand is balanced by the fluxes of energy supply ATPase ϭ ⌽ gly ATP ϩ␤ OxP Ϫ CK Ϫ ADK (15) where ␤ is the stoichiometric coefficient relating ATP production to O 2 utilization. Several of these fluxes are represented distinctly. The creatine kinase reaction is a Cleland (random bi-bi) reaction (44)
The previous metabolic flux expression used for oxidative phosphorylation (43) was modified to account for Pi according to the previous model developed (5) to simulate ATP production in mitochondria of cardiac muscle
For comparison with minimally invasive measurements, model outputs include V O2 and O2 saturation in blood and tissue. The rate of muscle V O2 per volume of muscle is (18) where C A-V T (t) is the arteriovenous concentration difference of total (free and bound) O2. The equilibrium relationship between total and free O2, e.g., arterial O2 (C O2 ,art F ), is presented in APPENDIX B (43) .
Simulation Strategy
This model is intended to simulate and predict the spatially distributed concentrations of O 2, lactate, pyruvate, Cr, PCr, AMP, and metabolites of the glycogenolytic pathway. Specifically, the model is applied to analyze underlying metabolic and transport processes based on responses of the canine gastrocnemius muscle in situ to tetanic stimuli (23) (24) (25) under a variety of experimental conditions: 1) normoxia or hyperoxia, 2) spontaneous self-perfused (SP) or controlled PP Q patterns, and 3) O 2 utilization rate equivalent to 60% or 100% of peak, steady-state V O2 (V O 2 ss ) ( Table 1 ). Canine muscle was used for validation because of a readily available database containing direct measures of metabolic rate and many of its related components under different conditions: Q , muscle contraction frequency, and arterial O 2 content (23) (24) (25) .
In model simulations, the measured arterial concentration of free O 2 (C O2 , art F ) corresponding to normoxia or hyperoxia was applied. The simulations also incorporated the measured Q (t). Simulations of the corresponding O2 utilization rate are based on equivalent estimation of kATPase ( Table 2 ).
There are uncertainties about the glycogenolytic enzyme capacity used in this model. In particular, V max,f,i, reported in the computational study (44) to simulate the whole glycogenolytic process in skeletal muscle, was adapted to describe only the anaerobic glycogenolysis in our model. To lower the anaerobic glycogenolytic capacity to physiological levels, a glycogenolytic capacity fraction 0 Ͻ ␣ gly Ͻ 1 was introduced. The parameter ␣gly modifies the maximal flux rates (44) of key glycogenolytic reactions (Table 3 ). This fraction does not apply to the reactions of oxidative phosphorylation, creatine kinase, and adenylate kinase.
Model validation is based on the simulations of C (19) Of special interest are the averaged concentrations of ATP and O 2 (͗CATP͘ and ͗C F O 2 ,c͘) and fluxes of oxidative phosphorylation and ATPase (͗OxP͘ and ͗ATPase͘). Under steady-state conditions, the potential metabolic and transport limitations become apparent from several spatially averaged outputs. The average iPO 2 ͗iPO2͘, which is directly proportional to the average free O2 concentration in cells ͗C that energy supply is meeting energy demand. The maximal flux fraction ␣ gly was increased to explore the effects of glycogenolytic capacity on ͗iPO2͘ at higher ATP demand. Although there is no evidence that the full glycogenolytic capacity is used during the canine muscle contractions that were modeled, this condition may be relevant for intense human exercise. Also, to examine the effects of O 2 transport limitations on the ͗iPO2͘-WR relationship, physiologically normal and elevated values of blood perfusion and PS were simulated.
Parameter Estimation and Numerical Solution
Values of most parameters in this model (Table 7) are available from previous studies: transport parameters of pyruvate and lactate (14) , concentrations of arterial lactate and pyruvate (50) , and parameters of the metabolic fluxes (Tables 3-6 ) (44, 63a). These parameter values apply to all experiments and are independent of the input conditions. The value of T lac was chosen so that simulation of lactate output was the same as that measured by Grassi et al. (23) at submaximal metabolic intensity under constant Q . T pyr was similarly determined from pyruvate uptake data (20) .
In these simulations, most model parameter values are independent of the experimental conditions; therefore, their values are the same.
Other parameter values for simulation depend on the experimental conditions (Tables 1 and 2 ). Values of muscle volume (V mus) were obtained from experimental measurements of muscle weight and typical muscle density (23) (24) (25) . Values of k ATPase for resting and working muscle and for Vmax,OxP were estimated by least-squares optimization (43) using measurements of arteriovenous O2 difference obtained under hyperoxic conditions. These experiments were conducted with constant PP Q and injection of a drug (RSR-13) that causes a rightward shift in the O2-Hb dissociation curve (24) . In simulating the muscle response to contraction, values of kATPase for resting and working muscle were estimated to fit steady-state V O2 data for each experimental condition (23) (24) (25) . The value of Vmax,OxP was unchanged for simulations under all experimental conditions. The initial model concentrations depend on the experimental conditions: arterial metabolite concentrations and Q (Tables 1 and  2 ). These are obtained by numerical solution of the model equations using parameter values of Tables 3-7. The steady-state concentration values are the initial conditions at which the stimulus is applied.
For numerical solution of the model equations, the spatial derivatives are discretized to convert partial differential equations to ordinary differential equations (method of lines) using a welldeveloped code (DSS/2) (61). Consequently, the model consists of a set of ordinary differential-difference equations that constitute an initial-value problem solved using a robust algorithm for stiff systems (DLSODE) (27) . The parameter estimation was obtained by minimizing the objective function represented by the difference between model simulation and experimental data. The objective function is minimized by numerical optimization using an adaptive, nonlinear algorithm (DN2FB; http://www.netlib.org) (16) . Depending on the operating point in parameter space, changes of just 10% in the parameters of interest can produce significant differences in the simulated outputs. To simulate the metabolic response to contraction under blood SP conditions, Q and V O2 data of canine muscle under different contraction frequencies (22-25, 28, 31, 39, 66) , were used (see Fig. 8A ).
RESULTS

Parameter Estimation and Model Validation
By fitting simulated arteriovenous O 2 differences to experimental data obtained under the conditions reported in Table 1 (hyperoxia ϩ RSR-13, PP), optimal estimates were obtained for oxidative phosphorylation maximal flux rate (V max,OxP ; Table 3 ) as well as k ATPase in resting (k ATPase,R ) and working (k ATPase,S ) muscle ( Table 2) . The model simulations produced dynamic outputs comparable to experimental data (Fig. 2) of Q , arteriovenous O 2 concentration difference (C A-V ), and muscle uptake (V O 2 ϭ Q C A-V ). The validity of the mathematical model was tested by comparison of simulated muscle responses under various conditions (Tables 1 and 2 ) with corresponding experimental data (23) (24) (25) . Values of V max,OxP and other common parameters, estimated from previous studies, were assumed to be the same under all experimental conditions (Tables 3-7) .
In response to energy demand corresponding to muscle contraction, the model simulations produced dynamic outputs comparable to experimental data (Figs. 3-5) for Q , C A-V , and V O 2 . Simulated responses of other variables are predictions for which corresponding experimental data are not available. Model simulation of V O 2 , obtained during normoxia with spontaneous (SP) and PP Q , shows that the dynamic and steady-state responses are not noticeably affected by the muscle Q pattern at 60% of V O 2peak (Fig. 3) . Apparently, differences in Q are compensated by changes in C A-V . With constant perfusion and hyperoxia, C A-V shows a delayed dynamic response with a larger slope (Fig. 4) . The delayed dynamic response with a larger slope is still evident in the V O 2 dynam- (Fig. 5) . In addition to these outputs, the mathematical model predicts a myoglobin (Mb) saturation fraction of ϳ0.95 at rest. Also, during the first 30 s of muscle contraction, the Mb saturation fraction and the iPO 2 decrease rapidly, which contributes to an increase of the capillary-tissue O 2 gradient.
Factors Affecting Metabolic Response to Higher Energy Demand
Metabolic responses to contraction. To simulate responses to higher rates of muscle contraction or ATP demand, equivalent higher values of k ATPase were used. The model simulations reported in Figs. 6 and 7 were obtained using model parameters corresponding to 100% of V O 2peak with PP Q of 101 ml·100 g Ϫ1 ·min Ϫ1 through the transition from rest to contractions. The k ATPase value predicted at 100% of V O 2peak (i.e., maximal k ATPase in the canine gastrocnemius muscle preparation) is labeled k ATPase,max (Figs. 6 -8 ). As ATP demand (i.e., k ATPase ) increases during submaximal muscle contractions, the average O 2 (͗ePO 2 ͘-͗iPO 2 ͘) gradient (Figs. 6C and  7C ) and muscle V O 2 (Figs. 6B and 7B ) increase, while ͗iPO 2 ͘ decreases (Figs. 6A and 7A) . ͗C ATP ͘ is constant over a wide range of submaximal energy demand but decreases at higher energy demand (Figs. 6D and 7D) .
Effects of glycolytic capacity. Changes in glycolytic capacity were simulated by changing the maximal metabolic flux rate parametersV max,f,i associated with the glycolytic pathway as determined by ␣ gly . Increased ␣ gly changes the steady-state relationships of O 2 gradient, ͗iPO 2 ͘, and V O 2 with contraction intensity (Fig. 6) . For the same ATP demand (but before significant ͗C ATP ͘ decrease), an increase in ␣ gly lowers V O 2 (Fig. 6B) and O 2 gradient (Fig. 6C ) but increases iPO 2 (Fig. 6A) .
Effects of O 2 diffusion. Changes in the O 2 diffusion rate from capillaries to myocytes were simulated by changing the capillary PS via its maximum value (PS max ). For different PS max , the steady-state relationships of iPO 2 , V O 2 , O 2 gradient, and ͗C ATP ͘ vary with energy demand (Fig. 7) . At low or high ATP demand, lower values of PS max result in lower ͗iPO 2 ͘ and higher O 2 gradient. At lower energy demand, V O 2 and C ATP are unaffected by PS max (Fig. 7) , while at higher energy demand, V O 2 and C ATP are reduced at lower PS max . The energy demand at which C ATP begins to decrease is lower with lower PS max (Fig. 7) .
Effects of convective transport. Figures 6 and 7 show the effects of increased PP Q at all contraction intensities. In addition, ͗iPO 2 ͘ was simulated for physiological values of SP Q Fig. 4 . Q , arteriovenous O2 difference, and V O2 for PP canine gastrocnemius muscle stimulated at 60% of V O2peak under normoxia and hyperoxia. Experimental data are from Refs. 23 and 24. Vertical line denotes transition between rest and contraction. Note that hyperoxia had no effect on these responses at this submaximal metabolic rate. and V O 2 . A variety of experimental data were used (22-25, 28, 31, 39, 66) to determine an empirical linear relationship between steady-state Q and V O 2 (Fig. 8A) . The relationship was used in the model to estimate k ATPase for several metabolic rates under physiological (spontaneous) perfused Q to examine the effects of Q on ͗iPO 2 ͘, ͗ePO 2 ͘-͗iPO 2 ͘ gradient, V O 2 , and ATP. Optimal estimates for k ATPase were obtained for steadystate Q values, which are model inputs. Under spontaneous Q , V O 2 , O 2 gradient, and C ATP are similar to values obtained with elevated (controlled) Q (not shown). However, the simulated ͗iPO 2 ͘ is higher with elevated muscle perfusion than with normally perfused muscle at low contraction rates (Fig. 8B) . At higher contraction rates, ͗iPO 2 ͘ is similar under both flow conditions. At higher energy demand, as represented by a large k ATPase , a V O 2 plateau and decline in ͗C ATP ͘ appear (Figs. 6B, 6D , 7B, and 7D). This occurs when iPO 2 decreases enough (Figs. 6A and 7A) to exert feedback control on the oxidative phosphorylation flux. In this situation, oxidative phosphorylation and anaerobic processes (e.g., glycogenolysis, creatine kinase, and adenylate kinase) cannot meet the energy demand without a reduction in ͗C ATP ͘. For the same muscle oxidative capacity (V max,OxP ), higher glycolytic capacity (i.e., ␣ gly ) or PS (i.e., PS max ) allows the metabolic system to perform at higher energy demand without a decrease in ͗C ATP ͘ (Figs. 6 and 7) .
Comparison with human experimental data. According to the proportionality between k ATPase and ATP demand, it is assumed that k ATPase is proportional to WR [i.e., (k ATPase Ϫ k ATPase,R )/(k ATPase,max Ϫ k ATPase,R ) ϭ WR/WR max ]. Therefore, the simulated iPO 2 values in contracting canine muscle were compared with those obtained experimentally in humans (57, 49) . At rest, simulated ͗iPO 2 ͘ was similar to the NMR-measured iPO 2 in humans (58) . Simulations were performed with a range of PS max values, with WR increased until C ATP decreased to 70% of its initial value. For each PS max , WR max in the experimental canine model corresponds to specific k ATPase,max values at Q ϭ 100 ml·100 g Ϫ1 ·min Ϫ1 according to the linear V O 2 -Q relationship (Fig. 8A) . Under spontaneous Q , the effect of PS max on ͗iPO 2 ͘ is similar to that observed with elevated blood perfusion (Fig. 9) . Qualitatively, the model's prediction of the iPO 2 -WR relationship is similar to that found by Molé et al. (49) and Richardson et al. (57) . At low WR, the simulated iPO 2 is higher than that observed during knee extensor exercise (57).
At higher WR, the iPO 2 values measured during knee extensor (57) and plantar flexion (49) exercises were close to those simulated at low PS max .
DISCUSSION
Experimental studies with human skeletal muscles show apparently contradictory results with respect to the change of iPO 2 with increased energy demand (WR). One study (49) showed that iPO 2 decreased linearly as WR increased, while others (55, 57) found that iPO 2 decreased with increased WR to a plateau ϳ60% of V O 2peak . Because these studies examined different muscles during different types of exercise, their results are difficult to compare directly. Furthermore, reliable estimates of iPO 2 are very difficult to obtain because of heterogeneities within the investigated muscles. However, these different relationships can be explained by a quantitative analysis with our mechanistic, mathematical model that simulates O 2 transport and cellular metabolism in canine skeletal muscle. The canine muscle preparation was chosen to validate the mathematical model and to quantitatively relate the modelsimulated ͗iPO 2 ͘ changes to energy demand under conditions of normal (spontaneous) and elevated Q , as well as different O 2 diffusion and metabolic characteristics, during contraction. In contrast to the experimental conditions in human studies, the canine preparation allows control of muscle Q to obtain key information on factors affecting muscle V O 2 kinetics. Model simulations show that the different experimental iPO 2 -WR relationships are valid for different experimental conditions. The response of ͗iPO 2 ͘ to ATP demand depends on O 2 convection, O 2 diffusion, and metabolic capacity. In particular, the rate coefficient of PS appears to be the main controller of O 2 diffusion. Model simulations suggest that iPO 2 
Model Characteristics, Simulations, and Predictions
The mathematical model used in this study combines a model of anaerobic glycogenolysis (44) with a model of O 2 transport and utilization (43) . To simulate the ͗iPO 2 ͘-WR relationship at higher ATP demand, the model incorporates O 2 transport (i.e., convection and diffusion) with aerobic and anaerobic processes. The aerobic processes include oxidative phosphorylation, while the anaerobic processes include the creatine kinase reaction and glycogenolysis to sustain ATP supply to meet the demand. The glycogenolytic model (44) was modified to simulate experiments with perfused canine muscle in situ under different conditions using a scaling parameter ␣ gly for the maximal glycogenolytic fluxes. When ␣ gly ϭ 0.2, the glycogenolytic fluxes involving ATP (⌽ gly ATP ) contribute ϳ10% of the ATP required to meet moderate ATP demand. This corresponds to the percentage found for a canine muscle preparation during moderate contraction intensity (11, 12) . However, if ␣ gly is set at Ͼ0.2, then the simulated tissue lactate concentration and glycolytic contributions to the energy demand are greater than those found under physiological conditions for canine muscle contraction (30) .
Model simulations describe C A-V and V O 2 responses to different Q and O 2 input concentrations to energy demand (Figs. 2-5 ). These mimic experimental responses from electrically stimulated canine gastrocnemius muscle (23) (24) (25) . While steady-state ATP demand must be estimated for each condition, the model is able to successfully predict V O 2 and C A-V dynamics without adjustment of any parameters. Simulations (Figs. 2-4) show that, in the canine gastrocnemius, convective transport does not limit oxidative metabolism at submaximal energy demand (23, 24) but could limit it at maximal energy demand (Fig. 5 ), e.g., 100% V O 2peak (25) . At maximal contraction intensity, the rise time of V O 2 dynamics in response to a step increase of energy demand is shorter under elevated PP (controlled) Q than under SP (spontaneous) Q . This indicates a convective limit to O 2 transport rate from blood to tissue, because controlled, elevated Q can meet O 2 demand more quickly. Nevertheless, factors such as oxidative and glycolytic capacity and O 2 convection (SP and PP) patterns, as well as diffusion, can affect the relationship between iPO 2 and energy demand. These results provide the basis for model validity with respect to mechanisms of the V O 2 dynamics. Consequently, the model is sufficiently robust to predict underlying responses associated with O 2 transport and metabolism that have not been measured.
Relationship Between iPO 2 and Energy Demand
Effect of PS on intracellular O 2 and O 2 diffusion. When the O 2 transport rate increases to match ATP demand, the O 2 gradient adjusts according to PS max . With increased energy demand from low to high contraction rate, the blood-tissue O 2 gradient increases linearly (Fig. 7C) , which causes O 2 diffusion to increase linearly as well. At lower PS max , the O 2 gradient is increased for the same k ATPase value (Fig. 7C) to provide enough muscle O 2 delivery and sustain the same muscle V O 2 and O 2 utilization at submaximal energy demand (Fig. 7B) . Consequently, at every metabolic rate, the O 2 gradient is higher and the average iPO 2 or ͗iPO 2 ͘ is lower than the values obtained at higher PS max (Figs. 7A and 9 ), although V O 2 is unchanged (Fig. 7C) . Thus, under physiological conditions, PS max can affect ͗ePO 2 ͘ and ͗iPO 2 ͘ temporal profiles during muscle contraction. At higher energy demand and lower PS max , the O 2 gradient and, therefore, O 2 diffusion cannot increase further, because ͗iPO 2 ͘ is close to zero (Fig. 7A) . As a result, oxidative phosphorylation is limited according to Eq. 17 and V O 2 reaches a plateau (Fig. 7B) and for ͗iPO 2 ͘ ϭ 10 mmHg (Fig. 7, A and B) . Although ͗iPO 2 ͘ is greater than the critical (10, 49, 55, 57) report a rapid decline in Mb saturation fraction at the onset of contraction, which reflects a rapid decrease in iPO 2 . This dynamic response is also evident in model simulations. As a result, the simulated O 2 gradient from blood capillary to tissue increases, which enhances O 2 diffusion during muscle contraction, as indicated by other modeling (43) and experimental (62) studies.
PS can also affect the relationship between ͗iPO 2 ͘ and WR (%WR max ; Fig. 9 ). Simulations show that ͗iPO 2 ͘ decreases significantly as %WR max increases in the lower range of WR. The rate of decrease is lower at higher WR, especially for lower values of PS max . These results indicate that the experimental iPO 2 -%WR max relationships reported in the plantar flexion (49) and knee extensor (57) studies, which appear to be different, may be produced by different muscle PS, which depends on the experimental conditions.
Resolution of apparent experimental discrepancies. These simulations explain quantitatively how O 2 diffusion may limit muscle oxidative metabolism at maximal contraction rate, as suggested from canine muscle data (25, 29) . However, at submaximal contraction, V O 2 on-kinetics are not affected by arterial O 2 content, implying the absence of O 2 diffusion limitation (24) . Moreover, our model simulations indicate that the differences between the results of Molé et al. (49) and Richardson et al. (57) are not mutually exclusive. These differences can be explained by differences in the interaction of transport and metabolic processes between plantar flexion (49) and knee extensor exercise (57) .
Effects of Q on iPO 2 . In model simulations shown in Figs. 6 and 7, Q is at a constant, elevated level of 101 ml·100 g Ϫ1 ·min
Ϫ1
. However, physiological Q is often linearly related to V O 2 (60) . Therefore, model predictions of ͗iPO 2 ͘ under physiological Q were investigated to see how they might differ from model predictions under elevated Q . At low contraction intensity, when spontaneous Q is low, model predictions of the O 2 gradient and ͗iPO 2 ͘ differ from those found when Q is elevated (Fig. 8) . At the same ATP demand, muscle utilizes the same amount of O 2 to provide ATP, whether its Q is spontaneous or elevated. At lower energy demand, O 2 delivery is lower with spontaneous than with elevated Q . Contraction intensity has a greater effect on tissue O 2 when Q is low (Fig.  8A ) than when it is elevated (Figs. 6 and 7) . For the same V O 2 and utilization at lower energy demand, steady-state ͗iPO 2 ͘ must be much lower in the spontaneous than in the elevated Q condition. Simulations show that ͗iPO 2 ͘ at higher energy demand (Fig. 8B) is similar when spontaneous and elevated Q are similar (Fig. 8A) .
Effects of glycogenolytic capacity. Greater glycolytic capacity (␣ gly ) is associated with higher ͗iPO 2 ͘, but lower V O 2 (Fig.  6, A-B) and oxidative phosphorylation. Under this condition, glycogenolysis (through gly ATP ) consumes more ADP and produces more ATP for the same energy demand. This lower ADP concentration reduces oxidative phosphorylation by feedback mechanisms; therefore, the oxidative contribution to the energy demand is smaller in muscle with higher glycolytic capacity. When ␣ gly is higher, ͗iPO 2 ͘ reaches a plateau at slightly higher energy demand due to the smaller oxidative contribution. In our mathematical model, ͗iPO 2 ͘ is indirectly related to the glycogenolytic capacity through the effect of ATP/ADP changes on the aerobic and anaerobic metabolic fluxes. These regulation mechanisms are in agreement with those proposed in a previous in silico study (7) .
Model Achievements, Limitations, and Future Developments
Factors affecting O 2 transport. Our model not only simulated an iPO 2 plateau similar to the results of Richardson et al. (55) , but it also predicted a V O 2 plateau not yet observed. Model simulations show that, at the same energy demand and V O 2 , iPO 2 can be drastically different because of the capillary PS (Fig. 7) . Corresponding to the experimental data (55), these simulations suggest that PS max may increase with energy demand. In the mathematical model, PS is represented by an empirical time function associated with a step change in Q , which can be justified by experimental studies (8, 65) . Although this model assumes that PS max is constant and does not vary with energy demand, previous canine studies have reported an increase of PS with Q and energy demand (19) . Even when Q is held constant, PS may increase with energy demand (17) .
Changes in PS may be related to physical factors such as vasodilation, capillary recruitment, and RBC spacing in capillaries (18, 32, 52, 53) , which have been proposed to explain an increase in O 2 delivery during contraction. A mechanistic mathematical model is required to investigate the relationship between PS and these factors (18, 26) and their effects on O 2 transport at the microvascular level. This study does not incorporate such mechanisms that determine PS changes but, rather, deals with the phenomenological role of PS and blood-tissue O 2 gradient in determining the O 2 flux. Regardless of the underlying mechanisms, PS increases at the onset of muscle contraction. The conclusions reached from this study are based on simulated PS changes during exercise, which are consistent with previous studies (18, 26, 55) .
The mathematical model accounts for systemic Hct, but not capillary microvascular Hct. Capillary Hct, as measured in the microvasculature, is generally lower than systemic Hct due to differences in the velocity between plasma and RBCs (40) . Our model was developed to provide a sufficiently detailed description of the overall O 2 transport in the whole muscle without describing the microvascular effects. It allows direct comparison between simulated and measured PO 2 in blood and tissue domains, as well as between simulated PS and O 2 diffusion capacity experimentally determined by other groups (59) . Other specific models and analysis are required to study the effect of Hct differences at the microvascular level (4 (Fig. 9 ). This comparison, however, is limited by differences between humans and dogs, as well as differences in protocols, muscle fiber recruitment, maximal Q , and metabolic rate. Under the assumption that ATP demand changes proportionally with WR, the simulated results predict an iPO 2 -WR relationship qualitatively similar to that observed in humans.
PS and the O 2 gradient are not the only factors that can affect iPO 2 . Other factors might include O 2 transport between myocytes (34), Mb buffering within myocytes (33) , and the critical PO 2 of oxidative phosphorylation (45) . The sensitivity of iPO 2 to these factors may be relatively small, but important, under some conditions. Quantification of the significance of the model parameters PS max and ␣ gly on iPO 2 requires more experimental data under a wide range of physiological conditions.
Fiber recruitment may also affect the iPO 2 -WR relationship in exercising human muscle (3, 47) . The model applied in this work describes metabolic processes in electrically stimulated canine gastrocnemius muscle, where the predominant fibers are highly oxidative and all are recruited at the onset of muscle contraction. The simulated ͗iPO 2 ͘ reported in Fig. 9 is based on a mathematical model of canine muscle that does not take into account fiber-type composition. When type I and II fibers are recruited, muscle V O 2 and metabolic control may differ from the case when only type I fibers are recruited. This is a consequence of differences in glycolytic and oxidative capacity and perhaps the P/O ratio of fiber types.
Interpretation of iPO 2 changes with energy demand. Our model simulations show that the iPO 2 data of Richardson et al. (57) and Molé et al. (49) (Fig. 9) are not necessarily inconsistent when examined together. The extent to which differences exist between electrically stimulated canine gastrocnemius, human plantar flexion, and human knee extensor exercise may be attributed to experimental conditions that affect the maximal metabolic rate, which differs between muscles and species. The maximal power output is ϳ6.6 times higher for knee extensor (54) than plantar flexion (49) exercise. This difference in power output seems to reflect differences in the metabolic state of each muscle at its WR max ; at 100% WR max , ATP concentration remains at its resting value in plantar flexion (49) but is reduced by 30% in knee extension (2) .
In isometrically stimulated canine gastrocnemius muscle, there is no power output; however, the maximal V O 2 [ (25) ]. However, the slope of the linear Q -V O 2 relationship is similar for canine muscle (5.4 ml/ml; Fig. 8A ), knee extensor [5.6 ml/ml (54)], and plantar flexion [6.1 ml/ml (6)]. Although there are protocol differences in maximal metabolic rate and Q , higher O 2 delivery is balanced by higher V O 2 . Therefore, these differences between experimental protocols are not expected to affect the iPO 2 -WR relationship (Fig. 9) . We note that V O 2peak and Q max in canine perfused muscle (25) used to determine the maximal k ATPase ( Fig. 9; i.e., WR max ) are lower than those obtained for the same canine gastrocnemius model (V O 2max ϭ 27 ml·100 g Ϫ1 ·min Ϫ1 and Q max ϭ 2.1 l/min) (38) with a different protocol. The V O 2peak commonly reported for canine gastrocnemius studies may not be the true V O 2peak achievable in this canine muscle preparation. However, addressing the limitations in reaching V O 2peak in a canine muscle preparation is beyond the scope of this report. If the maximal V O 2 and Q obtained by Kelley et al. (38) are used to determine %WR max in the canine gastrocnemius, the model simulations reported in Fig. 9 would be leftward-shifted. However, these higher values do not alter the Q -V O 2 relationship. NMR-measured iPO 2 (49, 55, 57 ) was compared with modelsimulated ͗iPO 2 ͘ (Fig. 9) . The correct interpretation of this comparison of simulated and measured iPO 2 requires consideration of the NMR measurement limitations. In particular, iPO 2 measurement is affected by P 50 (i.e., PO 2 at which 50% of Mb is bound to O 2 ). The P 50 of skeletal muscle in vivo is still uncertain. Experimental values range from 1.5 to 5.5 mmHg (57) Fig. 9 , regardless of the exact P 50 .
Modeling oxidative and glycolytic systems. The minimal mathematical model used in this study is sufficient for evaluating key factors related to O 2 transport and metabolic limitations with respect to increased energy demand. The model components representing skeletal muscle glycogenolysis were adequate to analyze O 2 diffusion limitation at higher energy demand. If sufficient experimental data, such as dynamic changes of glycogenolytic metabolite concentrations and/or fluxes with contraction intensity, were available, better estimates of model parameters could be obtained to further quantify mechanistic processes. Such data are needed to quantitatively analyze the potential mechanisms by which glycolysis is activated at higher WR (13, 21) and how glycogen limitations might affect V O 2 (51) . To account for pH-dependent enzyme kinetics, another model of glycogenolysis could also be incorporated (63a).
The simulated V O 2 was obtained under the assumption that oxidative phosphorylation is controlled by ADP, P i , and iPO 2 according to previous experimental and modeling studies (5, 9, 43) . In contrast, an experimental study (10) reported that V O 2 is independent of ADP at the onset of contraction. For accurate prediction of key metabolite (e.g., ADP, NAD, and NADH) concentrations associated with regulation of phosphorylation and redox states in response to contraction, a model that distinguishes metabolic processes in cytosol and mitochondria is needed (46) . A more detailed model of cellular respiration that includes oxidative phosphorylation, tricarboxylic acid cycle, and ␤-oxidation (5, 41, 46) would be worth incorporating if additional data were available to investigate regulatory mechanisms of energy metabolism in vivo (37) . With this more detailed model, which would more accurately simulate NAD/ NADH transport and metabolism, the relationship between iPO 2 and the accumulation of anaerobic metabolic markers above the anaerobic threshold could also be investigated.
Experimental studies have observed a linear V O 2 -WR relationship in skeletal muscle across a wide range of contraction intensities (1, 54, 60) . Computational studies have attributed this linear relationship at higher exercise intensity to a parallel activation mechanism affecting oxidative phosphorylation (48) . Our model is based on feedback control of ADP and P i without the inclusion of detailed activation mechanisms previously proposed (48 (38) . Because maximal V O 2 at lower PS max is primarily limited by O 2 transport, inclusion of a parallel activation mechanism in our model would not significantly alter the simulated results and conclusion. Furthermore, in electrically (as opposed to neurally) stimulated muscle at the contraction intensities considered in this study, parallel activation may not occur (36, 42) .
Perspectives and Significance
Model simulations demonstrate that, depending on experimental conditions, the interaction of O 2 diffusion with oxidative and glycolytic processes can lead to different relationships between iPO 2 , V O 2 , and ATP demand (49, 57) 
Dynamic Mass Balance
The model is spatially distributed in blood and tissue compartments. All metabolites are present in the tissue compartment. The blood compartment only includes O 2, lactate, and pyruvate.
Tissue compartment. 
Metabolic Fluxes
Most of these fluxes are calculated using ordered bi-bi MichaelisMenten kinetics. The exceptions are the creatine kinase flux, the oxidative phosphorylation flux, and the ATPase flux.
The metabolic flux expression for each reaction is reported as follows.
Glycogen phosphorylase GPa ϭ V max,f,GPa C gly C P i K igly K P i Ϫ V max,r,GPa C gly C glp
GPb ϭ V max,f,GPb C gly C P i K iglyf K P i Ϫ V max,r,GPb C gly C g1p
where glycogen phosphorylase flux (⌿ GP) accounts for isozyme form A and B with a and b fractions as follows 
where ⌬, ⌬=, and L are computed with the following expressions
Triose phosphate isomerase TPI ϭ V max,f,TPI C gap
Glyceraldehyde-3-phosphate dehydrogenase GAPDH ϭ V max,f,GAPDH C gap C NAD C P i
where D is calculated as 
